Published online Oct 28, 2020. doi: 10.13105/wjma.v8.i5.411
Peer-review started: September 18, 2020
First decision: September 29, 2020
Revised: October 7, 2020
Accepted: October 27, 2020
Article in press: October 27, 2020
Published online: October 28, 2020
Processing time: 40 Days and 22.7 Hours
Endoscopic resection (ER) is deemed as an effective method for gastrointestinal neoplasia, polyp, gastric adenomas, early oesophageal, gastric and colorectal cancer. More and more people suffering from cardiovascular disease and/or cerebrovascular disease receive antithrombotic therapy which change patients’ coagulation status and may lead to high risk of postoperative bleeding after ER. The relationship between the postoperative bleeding after ER and antithrombotic agents is still uncertain.
This study explored the relationship between the postoperative bleeding after ER and antithrombotic agents.
The aim of this study is to identify whether the use of antithrombotic drugs increases the risk of the postoperative bleeding after ER by a systematic review and meta-analysis.
A systematic search was conducted on PubMed, Web of Science, Cochrane library. The Newcastle-Ottawa scale was used to evaluate the quality of studies. Stata 12.0 was used for statistical analysis. The odds ratio and 95%CI were calculated and heterogeneity was quantified using Cochran’s Q test and I2.
Total 66 studies were included in the meta-analysis. Pooled data suggested that antithrombotic therapy was significantly associated with postoperative bleeding after ER. The risk of postoperative bleeding after endoscopic submucosal dissection, endoscopic mucosal resection and polypectomy in the antithrombotic group was higher than the non-antithrombotic group.
The risk of postoperative bleeding after ER correlated with the types and management of antithrombotic agents by our meta-analysis.
Our results can guide the use of antithrombotic drugs before ER and evaluate the risk of postoperative bleeding.
